A Study of Neoadjuvant Bio-C/T Followed by Concurrent Bio-R/T in High-risk Locally Advanced Oral Squamous Cell Carcinoma
Conditions
Interventions
- DRUG: Cetuximab,Paclitaxel,Cisplatin
Sponsor
National Health Research Institutes, Taiwan
Collaborators
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]